CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C14404 | BRD-K37688416 | fipexide | -- | -- | -- | Details |
| C14405 | BRD-K37691127 | hinokitiol | -- | -- | -- | Details |
| C14406 | BRD-K37694030 | doxepin | HRH1; HRH2; SLC6A2; SLC6A4 | Histamine receptor antagonist | -- | Details |
| C14407 | BRD-K37696710 | BRD-K37696710 | -- | -- | -- | Details |
| C14408 | BRD-K37698302 | BRD-K37698302 | -- | -- | -- | Details |
| C14409 | BRD-K37708631 | BRD-K37708631 | -- | -- | -- | Details |
| C14410 | BRD-K37708699 | exisulind | -- | -- | -- | Details |
| C14411 | BRD-K37710486 | BRD-K37710486 | -- | -- | -- | Details |
| C14412 | BRD-K37714126 | BRD-K37714126 | -- | -- | -- | Details |
| C14413 | BRD-K37714784 | ABT-724 | DRD4 | Dopamine receptor agonist | -- | Details |
| C14414 | BRD-K37719063 | BRD-K37719063 | -- | -- | -- | Details |
| C14415 | BRD-K37720887 | SB-525334 | TGFBR1 | TGF beta receptor inhibitor | -- | Details |
| C14416 | BRD-K37721603 | BRD-K37721603 | -- | -- | -- | Details |
| C14417 | BRD-K37722208 | BRD-K37722208 | -- | -- | -- | Details |
| C14418 | BRD-K37722313 | BRD-K37722313 | -- | -- | -- | Details |
| C14419 | BRD-K37723606 | dioscin | -- | -- | -- | Details |
| C14420 | BRD-K37724316 | BRD-K37724316 | -- | -- | -- | Details |
| C14421 | BRD-K37724988 | BRD-K37724988 | -- | -- | -- | Details |
| C14422 | BRD-K37727696 | BRD-K37727696 | -- | -- | -- | Details |
| C14423 | BRD-K37728465 | BRD-K37728465 | -- | -- | -- | Details |
| C14424 | BRD-K37733161 | BRD-K37733161 | -- | -- | -- | Details |
| C14425 | BRD-K37740343 | BRD-K37740343 | -- | -- | -- | Details |
| C14426 | BRD-K37741838 | BRD-K37741838 | -- | -- | -- | Details |
| C14427 | BRD-K37743233 | BRD-K37743233 | -- | -- | -- | Details |
| C14428 | BRD-K37752193 | BRD-K37752193 | -- | -- | -- | Details |
| C14429 | BRD-K37760698 | BRD-K37760698 | -- | -- | -- | Details |
| C14430 | BRD-K37760996 | BRD-K37760996 | -- | -- | -- | Details |
| C14431 | BRD-K37762845 | BRD-K37762845 | -- | -- | -- | Details |
| C14432 | BRD-K37763427 | BRD-K37763427 | -- | -- | -- | Details |
| C14433 | BRD-K37764012 | PF-03758309 | PAK4 | P21 activated kinase inhibitor | -- | Details |
| C14434 | BRD-K37765157 | BRD-K37765157 | -- | -- | -- | Details |
| C14435 | BRD-K37766746 | BRD-K37766746 | -- | -- | -- | Details |
| C14436 | BRD-K37770214 | BRD-K37770214 | -- | -- | -- | Details |
| C14437 | BRD-K37774987 | BRD-K37774987 | -- | -- | -- | Details |
| C14438 | BRD-K37777176 | BRD-K37777176 | -- | -- | -- | Details |
| C14439 | BRD-K37779687 | BRD-K37779687 | -- | -- | -- | Details |
| C14440 | BRD-K37780492 | BRD-K37780492 | -- | -- | -- | Details |
| C14441 | BRD-K37788266 | BRD-K37788266 | -- | -- | -- | Details |
| C14442 | BRD-K37790543 | BRD-K37790543 | -- | -- | -- | Details |
| C14443 | BRD-K37792168 | denbufylline | -- | -- | -- | Details |
| C14444 | BRD-K37792492 | dolasetron | HTR3A | Serotonin receptor antagonist | -- | Details |
| C14445 | BRD-K37795187 | BRD-K37795187 | -- | -- | -- | Details |
| C14446 | BRD-K37795473 | BRD-K37795473 | -- | -- | -- | Details |
| C14447 | BRD-K37798499 | etoposide | TOP2A; TOP2B | Topoisomerase inhibitor | -- | Details |
| C14448 | BRD-K37803976 | BRD-K37803976 | -- | -- | -- | Details |
| C14449 | BRD-K37813153 | BRD-K37813153 | -- | -- | -- | Details |
| C14450 | BRD-K37814297 | acepromazine | -- | -- | -- | Details |
| C14451 | BRD-K37815632 | BRD-K37815632 | -- | -- | -- | Details |
| C14452 | BRD-K37820137 | BRD-K37820137 | -- | -- | -- | Details |
| C14453 | BRD-K37822854 | BRD-K37822854 | -- | -- | -- | Details |
| C14454 | BRD-K37830990 | BRD-K37830990 | -- | -- | -- | Details |
| C14455 | BRD-K37831546 | BRD-K37831546 | -- | -- | -- | Details |
| C14456 | BRD-K37838939 | BRD-K37838939 | -- | -- | -- | Details |
| C14457 | BRD-K37846922 | BRD-K37846922 | -- | -- | 3,3'-diindolylmethane | Details |
| C14458 | BRD-K37847786 | BRD-K37847786 | -- | -- | -- | Details |
| C14459 | BRD-K37848780 | BRD-K37848780 | -- | -- | -- | Details |
| C14460 | BRD-K37848804 | BRD-K37848804 | -- | -- | -- | Details |
| C14461 | BRD-K37848908 | ceforanide | -- | -- | -- | Details |
| C14462 | BRD-K37849751 | BRD-K37849751 | -- | -- | -- | Details |
| C14463 | BRD-K37850190 | BRD-K37850190 | -- | -- | -- | Details |
| C14464 | BRD-K37852224 | BRD-K37852224 | -- | -- | -- | Details |
| C14465 | BRD-K37856394 | BRD-K37856394 | -- | -- | -- | Details |
| C14466 | BRD-K37865504 | LY-2183240 | FAAH | FAAH inhibitor; FAAH reuptake inhibitor | -- | Details |
| C14467 | BRD-K37865727 | BRD-K37865727 | -- | -- | -- | Details |
| C14468 | BRD-K37865854 | BRD-K37865854 | -- | -- | -- | Details |
| C14469 | BRD-K37866276 | BRD-K37866276 | -- | -- | -- | Details |
| C14470 | BRD-K37869460 | BRD-K37869460 | -- | -- | -- | Details |
| C14471 | BRD-K37872081 | BRD-K37872081 | -- | -- | -- | Details |
| C14472 | BRD-K37872686 | tirofiban | ITGA2B; ITGB3 | Platelet aggregation inhibitor; Structural glycoprotein antagonist | -- | Details |
| C14473 | BRD-K37879473 | BRD-K37879473 | -- | -- | -- | Details |
| C14474 | BRD-K37879871 | BRD-K37879871 | -- | -- | -- | Details |
| C14475 | BRD-K37883585 | BRD-K37883585 | -- | -- | -- | Details |
| C14476 | BRD-K37884199 | M-PHENYLENEDIAMINE.2HCL | -- | -- | -- | Details |
| C14477 | BRD-K37885773 | WAY-262611 | -- | -- | -- | Details |
| C14478 | BRD-K37890730 | camptothecin | TOP1 | Topoisomerase inhibitor | -- | Details |
| C14479 | BRD-K37892442 | BRD-K37892442 | -- | -- | -- | Details |
| C14480 | BRD-K37900095 | BRD-K37900095 | -- | -- | -- | Details |
| C14481 | BRD-K37906141 | BRD-K37906141 | -- | -- | -- | Details |
| C14482 | BRD-K37906761 | BRD-K37906761 | -- | -- | -- | Details |
| C14483 | BRD-K37912617 | BRD-K37912617 | -- | -- | -- | Details |
| C14484 | BRD-K37916557 | SA-1457810 | -- | -- | -- | Details |
| C14485 | BRD-K37919122 | BRD-K37919122 | -- | -- | -- | Details |
| C14486 | BRD-K37920059 | BRD-K37920059 | -- | -- | -- | Details |
| C14487 | BRD-K37928755 | BRD-K37928755 | -- | -- | -- | Details |
| C14488 | BRD-K37929710 | BRD-K37929710 | -- | -- | -- | Details |
| C14489 | BRD-K37929770 | BRD-K37929770 | -- | -- | -- | Details |
| C14490 | BRD-K37931645 | BRD-K37931645 | -- | -- | -- | Details |
| C14491 | BRD-K37932103 | BRD-K37932103 | -- | -- | -- | Details |
| C14492 | BRD-K37933621 | BRD-K37933621 | -- | -- | -- | Details |
| C14493 | BRD-K37935437 | BRD-K37935437 | -- | -- | -- | Details |
| C14494 | BRD-K37937164 | BRD-K37937164 | -- | -- | -- | Details |
| C14495 | BRD-K37940862 | BRD-K37940862 | NPSR1 | Neuropeptide receptor antagonist | -- | Details |
| C14496 | BRD-K37942718 | BRD-K37942718 | -- | -- | -- | Details |
| C14497 | BRD-K37949240 | BRD-K37949240 | -- | -- | -- | Details |
| C14498 | BRD-K37949327 | etidronic-acid | PTPRS | Bone resorption inhibitor | -- | Details |
| C14499 | BRD-K37956279 | BRD-K37956279 | -- | -- | -- | Details |
| C14500 | BRD-K37957394 | BRD-K37957394 | -- | -- | -- | Details |
| C14501 | BRD-K37957530 | BRD-K37957530 | -- | -- | -- | Details |
| C14502 | BRD-K37958236 | BRD-K37958236 | -- | -- | -- | Details |
| C14503 | BRD-K37959950 | BRD-K37959950 | -- | -- | -- | Details |